People: Mitsubishi Tanabe Pharma Corp (MTZXF.PK)
MTZXF.PK on OTC Markets Group - US Other OTC and Grey Market
14.90USD
19 Mar 2013
14.90USD
19 Mar 2013
Price Change (% chg)
$0.27 (+1.85%)
$0.27 (+1.85%)
Prev Close
$14.63
$14.63
Open
$14.90
$14.90
Day's High
$14.90
$14.90
Day's Low
$14.90
$14.90
Volume
300
300
Avg. Vol
528
528
52-wk High
$15.63
$15.63
52-wk Low
$13.23
$13.23
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Michihiro Tsuchiya |
64 | 2009 | President, Executive President, Representative Director |
Kenichi Yanagisawa |
62 | 2012 | Senior Managing Executive Officer, Chief Director of Sales, Director |
Kuniaki Kaga |
60 | 2012 | Senior Managing Executive Officer, Chief Director of Research, Director of International Business, Representative Director |
Takashi Kobayashi |
56 | 2012 | Managing Executive Officer, Director |
Kenkichi Kosakai |
58 | 2011 | Managing Executive Officer, Director |
Masayuki Mitsuka |
57 | 2012 | Managing Executive Officer, Chief Director of Development, Director of Medical Science, Director |
Seiichi Murakami |
Managing Executive Officer | ||
Minoru Muramatsu |
Managing Executive Officer | ||
Koji Nakamura |
2011 | Managing Executive Officer, Chief Director of Medicine Manufacturing, President of Subsidiary | |
Tsutomu Anno |
Executive Officer, Deputy Chief Director of Sales, Director of Sales Promotion | ||
Shigeki Nakata |
Executive Officer, Deputy Chief Director of Sales | ||
Kuniyoshi Wada |
Executive Officer, Deputy Chief Director of Sales, President of Subsidiary | ||
Tetsuo Yoshikawa |
Executive Officer, Deputy Chief Director of Sales | ||
Kazuyuki Hirakoso |
Executive Officer, Director of Business Planning | ||
Akira Ishibashi |
Executive Officer, Chief Director of CMC | ||
Yoshiaki Ishizaki |
2011 | Executive Officer, Chief Director of Trust Insurance | |
Seiichi Kiso |
Executive Officer | ||
Takeshi Matsumoto |
Executive Officer, Manager of Research Screening Center in Main Research Unit | ||
Koji Noborihayashi |
Executive Officer, Director of Business Administration | ||
Masaaki Ochiai |
Executive Officer, Director of Human Resources Training | ||
Hiromi Okatake |
Executive Officer, Director of Law Affairs | ||
Kiyoto Onchi |
Executive Officer, Director of Distribution Promotion | ||
Shigehiko Hattori |
71 | 2011 | Independent Director |
Seishiro Yoshioka |
67 | 2011 | Independent Director |
Tatsuo Kuwajima |
Director of Accounting & Finance |
Biographies
| Name | Description |
|---|---|
Michihiro Tsuchiya |
Mr. Michihiro Tsuchiya has been serving as President, Executive President and Representative Director in Mitsubishi Tanabe Pharma Corporation since June 19, 2009. He is also serving as Director of Mitsubishi Chemical Holdings Corporation and KAITEKI Institute, Inc. He joined the Company in April 1976. His previous titles include Senior Managing Executive Officer, Director of Business Planning, Managing Executive Officer and Executive Vice President of the Company. He obtained his Doctorate degree in Pharmacy from Kyoto University. |
Kenichi Yanagisawa |
Mr. Kenichi Yanagisawa has been serving as Senior Managing Executive Officer, Chief Director of Sales and Director in Mitsubishi Tanabe Pharma Corporation since April 2012. He joined the Company in April 1973. He previously served as Manager of Products Development Center and Chief Director of Development in the Company. |
Kuniaki Kaga |
Mr. Kuniaki Kaga has been serving as Senior Managing Executive Officer, Chief Director of Research, Director of International Business and Representative Director in Mitsubishi Tanabe Pharma Corporation since April 2012. He used to work for Mitsubishi Chemical Holdings Corp. and another Japan-based company. |
Takashi Kobayashi |
Mr. Takashi Kobayashi has been serving as Managing Executive Officer and Director in Mitsubishi Tanabe Pharma Corporation since April 2012. He joined the Company in April 1980. He previously served as Director of Business Administration. |
Kenkichi Kosakai |
Mr. Kenkichi Kosakai has been serving as Managing Executive Officer and Director in Mitsubishi Tanabe Pharma Corporation since June 2011. He previously served as Executive Officer and Director of Accounting & Finance of the Company. He used to work for Mitsubishi Chemical Holdings Corp. and two other companies. |
Masayuki Mitsuka |
Mr. Masayuki Mitsuka has been serving as Managing Executive Officer, Chief Director of Development, Director of Medical Science and Director in Mitsubishi Tanabe Pharma Corporation since April 2012. He used to work for two other companies. |
Seiichi Murakami |
|
Minoru Muramatsu |
|
Koji Nakamura |
|
Tsutomu Anno |
|
Shigeki Nakata |
|
Kuniyoshi Wada |
|
Tetsuo Yoshikawa |
|
Kazuyuki Hirakoso |
|
Akira Ishibashi |
|
Yoshiaki Ishizaki |
|
Seiichi Kiso |
|
Takeshi Matsumoto |
|
Koji Noborihayashi |
|
Masaaki Ochiai |
|
Hiromi Okatake |
|
Kiyoto Onchi |
|
Shigehiko Hattori |
Mr. Shigehiko Hattori has been serving as Independent Director in Mitsubishi Tanabe Pharma Corporation since June 2011. He is also Chairman of the Board and Representative Director in Shimadzu Corp., as well as Director in two other companies. |
Seishiro Yoshioka |
Mr. Seishiro Yoshioka has been serving as Independent Director in Mitsubishi Tanabe Pharma Corporation since June 2011. He is also working for Osaka Gas Co., Ltd. |
Tatsuo Kuwajima |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Michihiro Tsuchiya |
-- |
Kenichi Yanagisawa |
-- |
Kuniaki Kaga |
-- |
Takashi Kobayashi |
-- |
Kenkichi Kosakai |
-- |
Masayuki Mitsuka |
-- |
Seiichi Murakami |
-- |
Minoru Muramatsu |
-- |
Koji Nakamura |
-- |
Tsutomu Anno |
-- |
Shigeki Nakata |
-- |
Kuniyoshi Wada |
-- |
Tetsuo Yoshikawa |
-- |
Kazuyuki Hirakoso |
-- |
Akira Ishibashi |
-- |
Yoshiaki Ishizaki |
-- |
Seiichi Kiso |
-- |
Takeshi Matsumoto |
-- |
Koji Noborihayashi |
-- |
Masaaki Ochiai |
-- |
Hiromi Okatake |
-- |
Kiyoto Onchi |
-- |
Shigehiko Hattori |
-- |
Seishiro Yoshioka |
-- |
Tatsuo Kuwajima |
-- |
As Of
Options Compensation
| Name | Options | Value |
|---|---|---|
Michihiro Tsuchiya |
0 | 0 |
Kenichi Yanagisawa |
0 | 0 |
Kuniaki Kaga |
0 | 0 |
Takashi Kobayashi |
0 | 0 |
Kenkichi Kosakai |
0 | 0 |
Masayuki Mitsuka |
0 | 0 |
Seiichi Murakami |
0 | 0 |
Minoru Muramatsu |
0 | 0 |
Koji Nakamura |
0 | 0 |
Tsutomu Anno |
0 | 0 |
Shigeki Nakata |
0 | 0 |
Kuniyoshi Wada |
0 | 0 |
Tetsuo Yoshikawa |
0 | 0 |
Kazuyuki Hirakoso |
0 | 0 |
Akira Ishibashi |
0 | 0 |
Yoshiaki Ishizaki |
0 | 0 |
Seiichi Kiso |
0 | 0 |
Takeshi Matsumoto |
0 | 0 |
Koji Noborihayashi |
0 | 0 |
Masaaki Ochiai |
0 | 0 |
Hiromi Okatake |
0 | 0 |
Kiyoto Onchi |
0 | 0 |
Shigehiko Hattori |
0 | 0 |
Seishiro Yoshioka |
0 | 0 |
Tatsuo Kuwajima |
0 | 0 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
